The following corrections were made with the structures attached: The mannose (Man), galactose (Gal) and glucose (Glc) in the inner and outer cores in Figure 11, the GlcNAc of ST2 in Scheme 13, and the Glc in 6B and GlcNAc in S. dysenteria of Table 3 should be in the d- instead of the l-configuration. The ring junction of biotin in Figure 31 should have “H” instead of “Me” indicated. The triazole in Figure 32 should have a 1,4- instead of 1,5-substitution pattern. Figure 11. A general structure for bacterial lipopolysaccharides (LPSs). Figure 31. Synthetic V3-targeting bnAb epitope. (a) Glycopeptides from JR-FL (left) and A244 (right) strains. (b) Structure of three-component vaccine bearing gp120 glycopeptide, T-helper epitope, and a TLR2 agonist adjuvant. (c) JR-FL strain-derived V3 glycopeptide. Figure 32. Three-component vaccine containing A244 derived V3 glycopeptide, a T-cell epitope, and a TLR2 agonist adjuvant. This article has not yet been cited by other publications. Figure 11. A general structure for bacterial lipopolysaccharides (LPSs). Figure 31. Synthetic V3-targeting bnAb epitope. (a) Glycopeptides from JR-FL (left) and A244 (right) strains. (b) Structure of three-component vaccine bearing gp120 glycopeptide, T-helper epitope, and a TLR2 agonist adjuvant. (c) JR-FL strain-derived V3 glycopeptide. Figure 32. Three-component vaccine containing A244 derived V3 glycopeptide, a T-cell epitope, and a TLR2 agonist adjuvant.

中文翻译：

---

糖复合物的校正：合成、功能研究和治疗开发


对所附结构进行了以下修正：图 11 中内核和外核中的甘露糖 (Man)、半乳糖 (Gal) 和葡萄糖 (Glc)，方案 13 中 ST2 的 GlcNAc，以及 6B 和 GlcNAc 中的 Glc表3中的痢疾沙门氏菌应该是d-构型而不是l-构型。图 31 中生物素的环状连接处应标有“H”而不是“Me”。图 32 中的三唑应具有 1,4-取代模式，而不是 1,5-取代模式。图 11. 细菌脂多糖 (LPS) 的一般结构。图 31. 合成的 V3 靶向 bnAb 表位。 (a) JR-FL（左）和 A244（右）菌株的糖肽。 (b) 含有 gp120 糖肽、T 辅助表位和 TLR2 激动剂佐剂的三组分疫苗的结构。 (c) JR-FL 菌株衍生的 V3 糖肽。图 32. 含有 A244 衍生的 V3 糖肽、T 细胞表位和 TLR2 激动剂佐剂的三组分疫苗。这篇文章尚未被其他出版物引用。图 11. 细菌脂多糖 (LPS) 的一般结构。图 31. 合成的 V3 靶向 bnAb 表位。 (a) JR-FL（左）和 A244（右）菌株的糖肽。 (b) 含有 gp120 糖肽、T 辅助表位和 TLR2 激动剂佐剂的三组分疫苗的结构。 (c) JR-FL 菌株衍生的 V3 糖肽。图 32. 含有 A244 衍生的 V3 糖肽、T 细胞表位和 TLR2 激动剂佐剂的三组分疫苗。